Genetic susceptibility to breast cancer

被引:244
作者
Mavaddat, Nasim [2 ]
Antoniou, Antonis C. [2 ]
Easton, Douglas F. [2 ]
Garcia-Closas, Montserrat [1 ,3 ]
机构
[1] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England
[3] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA
关键词
Breast cancer; Genetic susceptibility; Aetiology of breast cancer; BRCA1/2 mutation carriers; Pathology; GENOME-WIDE ASSOCIATION; BRCA2 MUTATION CARRIERS; KERATINOCYTE GROWTH-FACTOR; BILATERAL PROPHYLACTIC MASTECTOMY; ESTROGEN-RECEPTOR STATUS; REDUCING SALPINGO-OOPHORECTOMY; DEL PROMOTER POLYMORPHISM; AFRICAN-AMERICAN WOMEN; PROGESTERONE-RECEPTOR; FAMILIAL BREAST;
D O I
10.1016/j.molonc.2010.04.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic and lifestyle/environmental factors are implicated in the aetiology of breast cancer. This review summarizes the current state of knowledge on rare high penetrance mutations, as well as moderate and low-penetrance genetic variants implicated in breast cancer aetiology. We summarize recent discoveries from large collaborative efforts to combine data from candidate gene studies, and to conduct genome-wide association studies (GWAS), primarily in breast cancers in the general population. These findings are compared with results from collaborative efforts aiming to identify genetic modifiers in BRCA1 and BRCA2 carriers. Breast cancer is a heterogeneous disease, and tumours from BRCA1 and BRCA2 carriers display distinct pathological characteristics when compared with tumours unselected for family history. The relationship between genetic variants and pathological subtypes of breast cancer, and the implication of discoveries of novel genetic variants to risk prediction in BRCA1/2 mutation carriers and in populations unselected for mutation carrier status, are discussed. (C) 2010 Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies.
引用
收藏
页码:174 / 191
页数:18
相关论文
共 179 条
[1]  
ADNANE J, 1991, ONCOGENE, V6, P659
[2]   Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 [J].
Ahmed, Shahana ;
Thomas, Gilles ;
Ghoussaini, Maya ;
Healey, Catherine S. ;
Humphreys, Manjeet K. ;
Platte, Radka ;
Morrison, Jonathan ;
Maranian, Melanie ;
Pooley, Karen A. ;
Luben, Robert ;
Eccles, Diana ;
Evans, D. Gareth ;
Fletcher, Olivia ;
Johnson, Nichola ;
Silva, Isabel dos Santos ;
Peto, Julian ;
Stratton, Michael R. ;
Rahman, Nazneen ;
Jacobs, Kevin ;
Prentice, Ross ;
Anderson, Garnet L. ;
Rajkovic, Aleksandar ;
Curb, J. David ;
Ziegler, Regina G. ;
Berg, Christine D. ;
Buys, Saundra S. ;
McCarty, Catherine A. ;
Feigelson, Heather Spencer ;
Calle, Eugenia E. ;
Thun, Michael J. ;
Diver, W. Ryan ;
Bojesen, Stig ;
Nordestgaard, Borge G. ;
Flyger, Henrik ;
Doerk, Thilo ;
Schuermann, Peter ;
Hillemanns, Peter ;
Karstens, Johann H. ;
Bogdanova, Natalia V. ;
Antonenkova, Natalia N. ;
Zalutsky, Iosif V. ;
Bermisheva, Marina ;
Fedorova, Sardana ;
Khusnutdinova, Elza ;
Kang, Daehee ;
Yoo, Keun-Young ;
Noh, Dong Young ;
Ahn, Sei-Hyun ;
Devilee, Peter ;
van Asperen, Christi J. .
NATURE GENETICS, 2009, 41 (05) :585-590
[3]   Breast cancer in African-American women: differences in tumor biology from European-American women [J].
Amend, Kandace ;
Hicks, David ;
Ambrosone, Christine B. .
CANCER RESEARCH, 2006, 66 (17) :8327-8330
[4]   Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family [J].
Amundadottir, LT ;
Thorvaldsson, S ;
Gudbjartsson, DF ;
Sulem, P ;
Kristjansson, K ;
Arnason, S ;
Gulcher, JR ;
Bjornsson, J ;
Kong, A ;
Thorsteinsdottir, U ;
Stefansson, K .
PLOS MEDICINE, 2004, 1 (03) :229-236
[5]   Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database [J].
Anderson, WF ;
Chatterjee, N ;
Ershler, WB ;
Brawley, OW .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :27-36
[6]   Breast cancer heterogeneity: A mixture of at least two main types? [J].
Anderson, William F. ;
Matsuno, Rayna .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (14) :948-951
[7]   Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS) [J].
Andrieu, Nadine ;
Goldgar, David E. ;
Easton, Douglas F. ;
Rookus, Matti ;
Brohet, Richard ;
Antoniou, Antonis C. ;
Peock, Susan ;
Evans, Gareth ;
Eccles, Diana ;
Douglas, Fiona ;
Nogues, Catherine ;
Gauthier-Villars, Marion ;
Chompret, Agnes ;
van Leeuwen, Flora E. ;
Kluijt, Irina ;
Benitez, Javier ;
Arver, Brita ;
Olah, Edith ;
Chang-Claude, Jenny .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (08) :535-544
[8]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[9]   The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions [J].
Antoniou, A. C. ;
Cunningham, A. P. ;
Peto, J. ;
Evans, D. G. ;
Lalloo, F. ;
Narod, S. A. ;
Risch, H. A. ;
Eyfjord, J. E. ;
Hopper, J. L. ;
Southey, M. C. ;
Olsson, H. ;
Johannsson, O. ;
Borg, A. ;
Passini, B. ;
Radice, P. ;
Manoukian, S. ;
Eccles, D. M. ;
Tang, N. ;
Olah, E. ;
Anton-Culver, H. ;
Warner, E. ;
Lubinski, J. ;
Gronwald, J. ;
Gorski, B. ;
Tryggvadottir, L. ;
Syrjakoski, K. ;
Kallioniemi, O-P ;
Eerola, H. ;
Nevanlinna, H. ;
Pharoah, P. D. P. ;
Easton, D. F. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1457-1466
[10]   Models of genetic susceptibility to breast cancer [J].
Antoniou, A. C. ;
Easton, D. F. .
ONCOGENE, 2006, 25 (43) :5898-5905